Graphite Bio Current Ratio vs. Net Income

GRPHDelisted Stock  USD 2.67  0.05  1.84%   
Considering Graphite Bio's profitability and operating efficiency indicators, Graphite Bio may not be well positioned to generate adequate gross income at the moment. It has a very high risk of underperforming in January. Profitability indicators assess Graphite Bio's ability to earn profits and add value for shareholders.
For Graphite Bio profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Graphite Bio to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Graphite Bio utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Graphite Bio's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Graphite Bio over time as well as its relative position and ranking within its peers.
  
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey.
Please note, there is a significant difference between Graphite Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if Graphite Bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Graphite Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Graphite Bio Net Income vs. Current Ratio Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining Graphite Bio's current stock value. Our valuation model uses many indicators to compare Graphite Bio value to that of its competitors to determine the firm's financial worth.
Graphite Bio is rated # 4 in current ratio category among its peers. It is rated below average in net income category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Graphite Bio's earnings, one of the primary drivers of an investment's value.

Graphite Net Income vs. Current Ratio

Current Ratio is calculated by dividing the Current Assets of a company by its Current Liabilities. It measures whether or not a company has enough cash or liquid assets to pay its current liability over the next fiscal year. The ratio is regarded as a test of liquidity for a company.

Graphite Bio

Current Ratio

 = 

Current Asset

Current Liabilities

 = 
27.07 X
Typically, short-term creditors will prefer a high current ratio because it reduces their overall risk. However, investors may prefer a lower current ratio since they are more concerned about growing the business using assets of the company. Acceptable current ratios may vary from one sector to another, but the generally accepted benchmark is to have current assets at least as twice as current liabilities (i.e., Current Ration of 2 to 1).
Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors.

Graphite Bio

Net Income

 = 

(Rev + Gain)

-

(Exp + Loss)

 = 
(124.65 M)
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.

Graphite Net Income Comparison

Graphite Bio is currently under evaluation in net income category among its peers.

Graphite Bio Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in Graphite Bio, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Graphite Bio will eventually generate negative long term returns. The profitability progress is the general direction of Graphite Bio's change in net profit over the period of time. It can combine multiple indicators of Graphite Bio, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Graphite Bio, Inc., a clinical-stage gene editing company, engages in developing therapies for serious and life-threatening diseases in the United States. Graphite Bio, Inc. was incorporated in 2017 and is headquartered in South San Francisco, California. Graphite Bio operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 111 people.

Graphite Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on Graphite Bio. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Graphite Bio position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Graphite Bio's important profitability drivers and their relationship over time.

Use Graphite Bio in pair-trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Graphite Bio position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Graphite Bio will appreciate offsetting losses from the drop in the long position's value.

Graphite Bio Pair Trading

Graphite Bio Pair Trading Analysis

The ability to find closely correlated positions to Graphite Bio could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Graphite Bio when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Graphite Bio - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Graphite Bio to buy it.
The correlation of Graphite Bio is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Graphite Bio moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Graphite Bio moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Graphite Bio can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Use Investing Themes to Complement your Graphite Bio position

In addition to having Graphite Bio in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Crypto And Gold Thematic Idea Now

Crypto And Gold
Crypto And Gold Theme
Assets that cancel away each other volatility by providing diversification into gold investment combined with digital assets. The Crypto And Gold theme has 54 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Crypto And Gold Theme or any other thematic opportunities.
View All  Next Launch
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey.
You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.

Other Consideration for investing in Graphite Stock

If you are still planning to invest in Graphite Bio check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Graphite Bio's history and understand the potential risks before investing.
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Global Correlations
Find global opportunities by holding instruments from different markets
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
CEOs Directory
Screen CEOs from public companies around the world
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.